Natural health product · DIN 01923455
Palafer® CF
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed March 27, 2009; licence last revised February 7, 2024.
- DIN
- 01923455
- Licence holder
- Bausch & Lomb Inc.Rochester, New York, United States
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Transitional DIN
- First licensed
- March 27, 2009
- Licence last revised
- February 7, 2024
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Folate | 0.5 mg | |
| Ferrous fumarate100 mg Iron | 300 mg | 100 mg Iron |
| Vitamin C | 200 mg |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Iron therapy. For the prevention and treatment of iron and folic acid deficiencies. For the prevention and treatment of iron deficiency and iron deficiency anemia. Mineral supplement. Vitamin supplement. Helps reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy. A factor in the maintenance of good health. Helps the body to metabolize proteins and fat. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps to form red blood cells and helps in their proper function. Helps in connective tissue formation and wound healing. An antioxidant for the maintenance of good health. Helps to prevent Vitamin C deficiency. Helps to prevent folate deficiency. Additional information for health care practitioners: Prophylactic administration of Palafer CF should be discontinued at term. Iron therapy alone should be administered after parturition. Iron poisoning is rare in adults but serious acute poisoning in children can result from ingestion of doses in excess of 1 g. Doses of 1 g should be considered as toxic in children and therapy instituted as soon as possible. Serum iron levels above 500 mcg/100 mL can be presumptive evidence of poisoning; severe poisoning is usually associated with levels well above 1000 mcg/100mL. Symptoms may occur within about 30 minutes or may be delayed several hours. They are largely those of gastrointestinal irritation and necrosis with vomiting, diarrhea, tarry stools, hematemesis, fast and weak pulse, lethargy, low blood pressure, coma and signs of peripheral circulatory collapse. There may be a transient period of apparent recovery after 4 to 6 hours followed by a second crisis characterized by cyanosis, pulmonary edema, circulatory collapse, convulsion, and coma may then occur followed by death in 12 to 48 hours. Treatment; Milk should be given immediately and vomiting induced. Eggs and milk should then be fed (to form Iron-protein complexes) until it is possible to perform gastric lavage with 1% sodium bicarbonate solution (to convert the iron to a less soluble form). Gastric lavage should not be performed after the first hour of iron ingestion because of the danger of perforation due to gastric necrosis. If an iron-chelating agent such as deferoxamine mesylate is available, it should be utilized. BAL (dimercaprol) should not be used because it may form a toxic complex. Measures to combat shock, dehydration, blood loss and respiratory failure may be necessary.
Non-medicinal ingredients
FD&C Red #3; Magnesium stearate; FD & C Yellow #6; Talc; Purified water; Lactose Monohydrate; D&C Yellow #10; Titanium dioxide; Sodium lauryl sulfate; Sucrose; Gelatin; Povidone; FD & C blue #1; FD&C Red No. 2; Silicon dioxide
Selling or importing natural health products? A bulk check of a whole NPN list is coming if enough people want it: say you want it.